Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Lemiale F, Kong WP, Aky├╝rek LM, Ling X, Huang Y, Chakrabarti BK, Eckhaus M, Nabel GJ.

J Virol. 2003 Sep;77(18):10078-87.

2.

Virus-like particle and DNA-based candidate AIDS vaccines.

Yao Q, Bu Z, Vzorov A, Yang C, Compans RW.

Vaccine. 2003 Jan 30;21(7-8):638-43. Review.

PMID:
12531332
3.

Short communication: enhancement of immunogenicity of replication-defective adenovirus-based human immunodeficiency virus vaccines in rhesus monkeys.

Sun C, Zhang Y, Liu Y, Zhang M, Chen L.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):681-6. doi: 10.1089/AID.2010.0210. Epub 2011 Jan 8. Review.

PMID:
21083437
4.

Mucosal immune responses associated with polynucleotide vaccination.

Malone JG, Bergland PJ, Liljestrom P, Rhodes GH, Malone RW.

Behring Inst Mitt. 1997 Feb;(98):63-72. Review.

PMID:
9382771
5.

Vaginal immunization with recombinant gram-positive bacteria.

Medaglini D, Oggioni MR, Pozzi G.

Am J Reprod Immunol. 1998 Mar;39(3):199-208. Review.

PMID:
9526609
6.

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins.

Mooij P, Heeney JL.

Vaccine. 2001 Nov 12;20(3-4):304-21. Review.

PMID:
11672892
7.

Adenoviruses as vectors for delivering vaccines to mucosal surfaces.

Babiuk LA, Tikoo SK.

J Biotechnol. 2000 Sep 29;83(1-2):105-13. Review.

PMID:
11000466
8.

Adenoviral vectors for mucosal vaccination against infectious diseases.

Santosuosso M, McCormick S, Xing Z.

Viral Immunol. 2005;18(2):283-91. Review.

PMID:
16035940
9.

Development of adenoviral vector-based mucosal vaccine against influenza.

Tutykhina IL, Logunov DY, Shcherbinin DN, Shmarov MM, Tukhvatulin AI, Naroditsky BS, Gintsburg AL.

J Mol Med (Berl). 2011 Apr;89(4):331-41. doi: 10.1007/s00109-010-0696-0. Epub 2010 Nov 21. Review.

PMID:
21104066
10.

Baculovirus as vaccine vectors.

Madhan S, Prabakaran M, Kwang J.

Curr Gene Ther. 2010 Jun;10(3):201-13. Review.

PMID:
20394572
11.

Viral vaccination via the mucosal routes.

Ogra PL, Fishaut M, Gallagher MR.

Rev Infect Dis. 1980 May-Jun;2(3):352-69. Review.

PMID:
6997965
12.

Effect of administration route on the biodistribution and shedding of replication-deficient HAdV-5: a qualitative modelling approach.

Tiesjema B, Hermsen HP, van Eijkeren JC, Brandon EF.

Curr Gene Ther. 2010 Apr;10(2):107-27. Review.

PMID:
20222861
13.

Development of nonhuman adenoviruses as vaccine vectors.

Bangari DS, Mittal SK.

Vaccine. 2006 Feb 13;24(7):849-62. Epub 2005 Sep 23. Review.

14.

The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen.

Bramson JL, Wan YH.

Expert Opin Biol Ther. 2002 Jan;2(1):75-85. Review.

PMID:
11772342
15.

Nasal delivery of epitope based vaccines.

Olszewska W, Steward MW.

Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):161-71. Review.

PMID:
11516787
16.

Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Patterson LJ, Robert-Guroff M.

Expert Opin Biol Ther. 2008 Sep;8(9):1347-63. doi: 10.1517/14712598.8.9.1347 . Review.

17.

Adenovirus vector-based vaccines for human immunodeficiency virus type 1.

Barouch DH, Nabel GJ.

Hum Gene Ther. 2005 Feb;16(2):149-56. Review.

PMID:
15761255
18.

Replicating and non-replicating viral vectors for vaccine development.

Robert-Guroff M.

Curr Opin Biotechnol. 2007 Dec;18(6):546-56. Epub 2007 Dec 11. Review.

19.

Inflammation and adaptive immune responses to adenoviral vectors injected into the brain: peculiarities, mechanisms, and consequences.

Lowenstein PR, Castro MG.

Gene Ther. 2003 Jun;10(11):946-54. Review. No abstract available.

PMID:
12756415
20.

Modifying adenoviral vectors for use as gene-based cancer vaccines.

Basak SK, Kiertscher SM, Harui A, Roth MD.

Viral Immunol. 2004;17(2):182-96. Review.

PMID:
15279698

Supplemental Content

Support Center